Washington Officials Shut Down Cannabis Operations at Former Orchard Due to Prior DDT Use

April 12, 2023 · Ganjapreneur

Silhouette of a man on a hemp field in sunlight

Washington State cannabis regulators have stopped operations at several outdoor cannabis farms and processing facilities located on a former fruit orchard after testing found high levels of a dangerous pesticide used at the site decades ago, the Associated Press reports. The Liquor and Cannabis Board (LCB) found DDE at the site, a byproduct of the pesticide DDT which was banned in the U.S. in 1972.

LCB Spokesperson Brian Smith said that while the agency is “very concerned about the jobs and businesses” at stake by closing down the site, the agency felt “it needed to get a message out to our licensees and to take action for public safety.”

Regulators last week issued “administrative holds” on 16 producer licenses and two processing licenses in the area, forcing them to cease operations until further notice. It’s unclear how many businesses were affected as companies can hold multiple licenses in the state.

In an interview with the AP, Walden Cannabis CEO Anders Taylor called the LCB’s decision “completely arbitrary” and said the agency has not provided him with test results or warned him that the hold was coming.

The LCB is also working with businesses to determine whether products tainted with DDE contamination made it to market so they can be pulled from shelves. The agency is also asking the affected businesses to issue recalls.

This is likely to be the first time the LCB has issued an administrative hold related to the previous use of pesticides, and it is the first time it has issued a hold covering an entire geographic area rather than an isolated business, the board said in an email to the AP. DDE is not one of the pesticides screened for under the state’s cannabis testing protocols. (Full Story)

In category:Psychedelics
Tags:
Next Post

Nevada Senators Approve Bill To Create Psychedelics Working Group To Plan For ‘Safe, Accessible And Affordable’ Access

Nevada lawmakers have approved a revised bill that would create a new working group to study psychedelics and develop a plan to allow regulated access for therapeutic purposes. While the legislation before the Senate Health and Human Services Committee as…
Read
Previous Post

Small Trial Suggests DMT Can Improve Symptoms of Depression

A trial conducted by biotechnology company Small Pharma found that the psychedelic DMT could improve symptoms of depression when used in conjunction with therapy. In the study, which used intravenous DMT dosing, 14 participants out of 34 were in remission…
Read
Random Post

Liquor Stores to Start Selling Cannabis? - The Future Endgame for Weed May Be Playing Out in Pennsylvania

Pennsylvania legislators have developed three distinct proposals to achieve multiple objectives: legalizing recreational cannabis, delivering social justice to individuals with minor cannabis convictions, and maximizing the economic benefits of a billion-dollar industry. Their innovative plans will cater to various needs…
Read
Random Post

MedMen Closes All But Two of Its California Locations

MedMen, the multistate cannabis operator (MSO) that once held the largest cannabis franchise footprint in the U.S., has shut down all but two of its California-based cannabis shops, MJBizDaily reports. The closures follow a years-long downward trend for the Los Angeles-based company,…
Read
Random Post

Florida Sees More Consolidation as Medical Cannabis Sales Soar

Florida’s medical cannabis industry, already boasting a valuation at over $1.4 billion, continues to grow. And with potential recreational legalization this upcoming election season, the space will likely see some hefty deals. “Florida has already established itself with a sizeable medical…
Read
Random Post

Biden Approves Funding for Psychedelic Drug Research for Military Members

President Joe Biden signed off on a new defense bill that includes provisions for funding clinical trials on the therapeutic potential of psychedelic drugs for active-duty military personnel. The president approved 2024’s National Defense Authorization Act on Dec. 22, a week after…
Read